EUVIMEDEUVIMED entdecken
Crossref

HPLC-DAD method for the quantification of CBD, CBDA, Δ9-THC, and Δ9-THCA cannabinoids in medicinal formulations

A R Pereira, J M Magalhães Figueiredo, J V Macêdo De Almeida, N dos Santos Conceição, H Seibert França, N A dos Santos, W Romão

Planta Medica · 01.03.2026 · 92 (03) · 373

DOI: 10.1055/s-0045-1815332 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.03.2026. Verfasst von A R Pereira und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cannabis is one of the oldest plants cultivated and contains over 700 characterized compounds, including cannabinoids, with Δ 9 -THC and CBD being the most prominent. The lack of validated analytical methodologies for cannabinoid quantification can result in inaccurate dosages and potential adulteration. High-performance liquid chromatography with diode-array detection (HPLC-DAD) stands out as a robust and accessible tool for quality control. This study aims to develop and validate a methodology for quantifying cannabinoids (CBD, CBDA, Δ 9 -THC and Δ 9 -THCA) in different matrices. Oil samples were provided by legally authorized users. The matrix effect was evaluated to determine the method’s selectivity, and a student’s t -test revealed no significant differences in slopes for the analyzed cannabinoids. Calibration curves (0.6-6 μg mL −1 for CBD and Δ9-THC, and 0.1-6 μg mL −1 for CBDA and Δ9-THCA) demonstrated good linearity, with R 2 values≥0.9997, limits of detection (LODs) ranging from 9.39×10 −2 to 1.01×10 −1 μg mL −1 , and limits of quantification (LOQs) between 2.48×10 −1 and 3.07×10 −1 μg mL −1 . The results indicate that the method exhibits high selectivity, linearity, and sensitivity for analyses in different matrices. The absence of matrix effects further supports its reliability and applicability. However, method validation is ongoing, with precision and accuracy evaluations in progress, which are essential to confirm its robustness for routine analytical applications [ 1 ] [ 2 ]. Publication History Article published online: 05 March 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Zitieren

APA

Pereira, A. R., Figueiredo, J. M. M., Almeida, J. V. M. D., Conceição, N. D. S., França, H. S., Santos, N. A. D., & Romão, W. (2026). HPLC-DAD method for the quantification of CBD, CBDA, Δ9-THC, and Δ9-THCA cannabinoids in medicinal formulations. Planta Medica, 92(03), 373. https://doi.org/10.1055/s-0045-1815332

Vancouver

Pereira AR, Figueiredo JMM, Almeida JVMD, Conceição NDS, França HS, Santos NAD, et al. HPLC-DAD method for the quantification of CBD, CBDA, Δ9-THC, and Δ9-THCA cannabinoids in medicinal formulations. Planta Medica. 2026;92(03):373. doi:10.1055/s-0045-1815332

BibTeX
@article{Pereira2026,
  author = {Pereira, A R and Figueiredo, J M Magalhães and Almeida, J V Macêdo De and Conceição, N dos Santos and França, H Seibert and Santos, N A dos and Romão, W},
  title = {HPLC-DAD method for the quantification of CBD, CBDA, Δ9-THC, and Δ9-THCA cannabinoids in medicinal formulations},
  journal = {Planta Medica},
  year = {2026},
  volume = {92},
  number = {03},
  pages = {373},
  doi = {10.1055/s-0045-1815332}
}
Kostenlos starten →